Don't miss this amazing #TitanMedical #GLP Weight Loss Package SPECIAL!

1 month ago
61

#SEMAGLUTIDE & #TIRZEPATIDE WEIGHT LOSS THERAPY PACKAGE DISCOUNTS!
GLP LEVEL 1 $50 OFF!!!
GLP LEVEL 2 $100 OFF!!!
SEMAGLUTIDE WEIGHT LOSS THERAPY
(FDA Approved Injectable "Ares" Therapy)
This therapy can help reduce hunger to prevent overeating and regulate glucose levels to help your body process sugars more effectively.
BENEFITS:
• Slow stomach emptying. When digestion is slowed down, nutrients in food are released more slowly. This prevents blood sugar from spiking after a meal.
• Reduce sugar released from the liver. The liver can release extra sugar into the blood as needed. GLP-1 RAs prevent the liver from putting too much sugar into your bloodstream.
**************
TIRZEPATIDE WEIGHT LOSS THERAPY
(FDA Approved Injectable Therapy)
This therapy is a once-weekly injectable peptide for weight loss therapy which mimics hormones that are involved in blood sugar control and appetite, that can help prevent you from overeating and curb your appetite. May also improve how well your body breaks down sugars and fat. It’s the next step up from the Semaglutide therapy without the potential nausea side effect.
BENEFITS:
When used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers.
This therapy may assist with weight loss by signaling to your brain that you are full - so you eat less. Tirzepatide also slows the movement of food through your stomach so that you feel fuller longer.
--------------------
*You DO NOT need blood work done to get these therapies!!!
Call Titan Medical Center to learn how you can have a healthier, stronger life. We offer telemedicine from the comfort of your own home. Our Titan therapies are doctor prescribed & shipped directly to your doorstep from a U.S. licensed pharmacy! 727-389-3220 or http://titanmedicalcenter.com/

Loading comments...